MXPA03004195A - Combination therapy for estrogen-dependent disorders. - Google Patents
Combination therapy for estrogen-dependent disorders.Info
- Publication number
- MXPA03004195A MXPA03004195A MXPA03004195A MXPA03004195A MXPA03004195A MX PA03004195 A MXPA03004195 A MX PA03004195A MX PA03004195 A MXPA03004195 A MX PA03004195A MX PA03004195 A MXPA03004195 A MX PA03004195A MX PA03004195 A MXPA03004195 A MX PA03004195A
- Authority
- MX
- Mexico
- Prior art keywords
- estrogen
- combination therapy
- dependent disorders
- disorders
- dependent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Reproductive Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US71460500A | 2000-11-16 | 2000-11-16 | |
PCT/US2001/043847 WO2002039995A2 (en) | 2000-11-16 | 2001-11-06 | Combination therapy for estrogen-dependent disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA03004195A true MXPA03004195A (en) | 2003-09-22 |
Family
ID=24870727
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA03004195A MXPA03004195A (en) | 2000-11-16 | 2001-11-06 | Combination therapy for estrogen-dependent disorders. |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1341549A2 (en) |
JP (1) | JP2004536022A (en) |
KR (1) | KR20030051828A (en) |
CN (1) | CN1498112A (en) |
AU (1) | AU2002230464A1 (en) |
BR (1) | BR0115423A (en) |
CA (1) | CA2428249A1 (en) |
CZ (1) | CZ20031349A3 (en) |
EA (1) | EA200300572A1 (en) |
IL (1) | IL155817A0 (en) |
MX (1) | MXPA03004195A (en) |
NO (1) | NO20032206L (en) |
NZ (1) | NZ525720A (en) |
PL (1) | PL365904A1 (en) |
WO (1) | WO2002039995A2 (en) |
ZA (1) | ZA200303669B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9050378B2 (en) | 2003-12-10 | 2015-06-09 | Board Of Regents, The University Of Texas System | N2S2 chelate-targeting ligand conjugates |
GB0506759D0 (en) * | 2005-04-02 | 2005-05-11 | Medical Res Council | Combination treatment methods |
EP1891964A1 (en) * | 2006-08-08 | 2008-02-27 | AEterna Zentaris GmbH | Application of initial doses of LHRH analogues and maintenance doses of LHRH antagonists for the treatment of hormone-dependent cancers and corresponding pharmaceutical kits |
US10925977B2 (en) | 2006-10-05 | 2021-02-23 | Ceil>Point, LLC | Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications |
EP2148682A1 (en) * | 2007-04-23 | 2010-02-03 | Bayer Schering Pharma Aktiengesellschaft | Combination of progesterone-receptor antagonist together with a lutein-hormone-releasing hormone agonist and antagonist for use in brca mediated diseases |
CN101775054B (en) * | 2010-02-05 | 2012-12-26 | 常州佳尔科药业集团有限公司 | Synthesis method of 4-hydroxyl-4-alkene-3-ketone steroide compound |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9911582D0 (en) * | 1999-05-18 | 1999-07-21 | Pharmacia & Upjohn Spa | Combined method of treatment comprising an aromatase inhibitor and a further biologically active compound |
GB9930839D0 (en) * | 1999-12-30 | 2000-02-16 | Pharmacia & Upjohn Spa | Process for treating gynecomastia |
-
2001
- 2001-11-06 EA EA200300572A patent/EA200300572A1/en unknown
- 2001-11-06 CN CNA018189385A patent/CN1498112A/en active Pending
- 2001-11-06 JP JP2002542370A patent/JP2004536022A/en active Pending
- 2001-11-06 EP EP01990699A patent/EP1341549A2/en not_active Withdrawn
- 2001-11-06 WO PCT/US2001/043847 patent/WO2002039995A2/en active Application Filing
- 2001-11-06 KR KR10-2003-7006608A patent/KR20030051828A/en not_active Application Discontinuation
- 2001-11-06 MX MXPA03004195A patent/MXPA03004195A/en unknown
- 2001-11-06 CA CA002428249A patent/CA2428249A1/en not_active Abandoned
- 2001-11-06 IL IL15581701A patent/IL155817A0/en unknown
- 2001-11-06 AU AU2002230464A patent/AU2002230464A1/en not_active Abandoned
- 2001-11-06 BR BR0115423-0A patent/BR0115423A/en not_active IP Right Cessation
- 2001-11-06 PL PL01365904A patent/PL365904A1/en not_active Application Discontinuation
- 2001-11-06 CZ CZ20031349A patent/CZ20031349A3/en unknown
- 2001-11-06 NZ NZ525720A patent/NZ525720A/en unknown
-
2003
- 2003-05-13 ZA ZA200303669A patent/ZA200303669B/en unknown
- 2003-05-15 NO NO20032206A patent/NO20032206L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
PL365904A1 (en) | 2005-01-10 |
CZ20031349A3 (en) | 2004-05-12 |
ZA200303669B (en) | 2004-05-13 |
IL155817A0 (en) | 2003-12-23 |
KR20030051828A (en) | 2003-06-25 |
BR0115423A (en) | 2005-12-13 |
WO2002039995A3 (en) | 2003-05-01 |
EA200300572A1 (en) | 2004-06-24 |
JP2004536022A (en) | 2004-12-02 |
AU2002230464A1 (en) | 2002-05-27 |
CA2428249A1 (en) | 2002-05-23 |
WO2002039995A9 (en) | 2003-02-06 |
NZ525720A (en) | 2006-12-22 |
CN1498112A (en) | 2004-05-19 |
WO2002039995A2 (en) | 2002-05-23 |
EP1341549A2 (en) | 2003-09-10 |
NO20032206D0 (en) | 2003-05-15 |
NO20032206L (en) | 2003-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA03001419A (en) | Therapeutic combination. | |
GB0009606D0 (en) | Therapeutic combinations | |
EP1296699A4 (en) | Therapeutic agents - iii | |
GB0028429D0 (en) | Therapy | |
GB0012671D0 (en) | Therapeutic agents | |
GB0003397D0 (en) | Therapeutic agents | |
GB0004003D0 (en) | Therapeutic agents | |
ZA200202542B (en) | Treating sleep disorders using desloratadine. | |
MXPA03003599A (en) | Antiinflammation agents. | |
GB0126879D0 (en) | Combination therapy | |
GB0005789D0 (en) | Therapeutic agents | |
GB0007907D0 (en) | Therapeutic agents | |
GB0012214D0 (en) | Therapeutic agents | |
GB0008696D0 (en) | Therapeutic agents | |
GB0000564D0 (en) | Therapeutic agents | |
MXPA03004195A (en) | Combination therapy for estrogen-dependent disorders. | |
GB0108485D0 (en) | Combination therapy | |
GB0007376D0 (en) | Therapeutic agents | |
MXPA03001472A (en) | Compounds for the treatment of addictive disorders. | |
ZA200110046B (en) | Therapeutic agents. | |
IL147696A0 (en) | Combination therapy | |
GB0014908D0 (en) | Combination therapy | |
GB0013927D0 (en) | Combination therapy | |
GB0007740D0 (en) | Combination therapy | |
GB0014133D0 (en) | Combination therapy |